ArticleFood chemistry: X2026
A novel, cost-effective approach to cell-cultured milk production: Progesterone and MMP inhibition promote lactogenic differentiation in bovine mammary epithelial cells.
Article in Food chemistry: X, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recent advances in cellular agriculture have enabled the synthesis of cell-cultured milk components through hormonal regulation in bovine mammary epithelial cells (BMECs). Progesterone (PG) promotes proliferation and alveolar structure formation, whereas prolactin (PRL) induces milk secretory differentiation. However, the high-priced PRL remains a major limitation for cell-cultured milk production. Therefore, our study aimed to find a cost-effective alternative to PRL by identifying the mechanistic differences between proliferation and differentiation in BMECs. This insight enabled testing whether combining PG and an MMP-2/9 inhibitor could induce milk component production. The data demonstrated that a key mechanistic difference exists between PRL and PG regarding their regulation of MMP-2/9 activity. Combining PG with an MMP-2/9 inhibitor effectively promoted milk component production at levels comparable to PRL. These findings highlight the potential for cost-effective PG to replace expensive PRL for inducing lactogenic differentiation, offering the way for more affordable and commercially viable cell-cultured milk production.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.